365. Deputy Erin McGreehan asked the Minister for Justice, Home Affairs and Migration the total cost of the construction works and modular units provided at Castlerea Prison, Loughan House Open Centre, and Shelton Abbey Open Centre, with the costs broken down on a site-by-site basis and including all associated planning, construction, consultancy, and related project costs; the total cost of the construction and reno…
366. Deputy Erin McGreehan asked the Minister for Justice, Home Affairs and Migration the projected cost of demolishing the old Cork Prison site, including all associated preparatory, environmental, safety, consultancy, and site clearance works required to render the site safe and fully prepared prior to the commencement of the new construction works; and if he will make a statement on the matter. [50524/26]
367. Deputy Erin McGreehan asked the Minister for Justice, Home Affairs and Migration the total cost incurred to date by the Irish Prison Service in respect of the Organisation Dashboard Project; the costs associated with consultancy services, including payments made to a company (details supplied) and any other external providers; the costs on software development and procurement, software licensing, project managem…
368. Deputy Erin McGreehan asked the Minister for Justice, Home Affairs and Migration the average daily number of users who logged on to the Irish Prison Service Organisational Dashboard during each of the first five months of 2026, by month; the estimated annual costs associated with maintaining the Irish Prison Service Organisational Dashboard for the period January 2026 to January 2030, including software licensin…
545. Deputy Erin McGreehan asked the Minister for Health the status of the proposed EU Common Training Framework (CTF) for physiotherapists; if her Department or CORU has taken a formal position on its potential introduction; the measures being considered to ensure that any future regulatory framework maintains patient safety and professional standards, particularly in light of variations in physiotherapy training ac…
124. Deputy Erin McGreehan asked the Minister for Transport if he is aware that the current parking provision at Dundalk Clarke railway station is insufficient to meet demand; the number of commuters being turned away or forced to park elsewhere on a daily basis; whether this shortage is undermining the use of public transport along the Dundalk-Dublin rail corridor; and if he will detail the specific actions being ta…
161. Deputy Erin McGreehan asked the Minister for Enterprise, Tourism and Employment whether consideration has been given to the development of a radiopharmaceutical manufacturing and innovation sector in Ireland; and potential economic and strategic benefits associated with such development. [50122/26]
292. Deputy Erin McGreehan asked the Minister for Health when it was decided by her Department and agreed with the Health Research Consent Declaration Committee (HRCDC) that persons making applications to the Minister for membership of the Committee would be informed that they must instead make their applications through the Committee; if that agreement was formally recorded by the Department and the HRCDC: if the ar…
293. Deputy Erin McGreehan asked the Minister for Health whether her Department considered the data protection implications of the arrangement with the Health Research Consent Declaration Committee (HRCDC) whereby it requires applicants for membership of the Committee to provide their personal data to the Committee without a statutory basis for that requirement. [49988/26]
294. Deputy Erin McGreehan asked the Minister for Health the reason the Health Research Consent Declaration Committee is able to periodically publicly invite expressions of interest for membership of the committee. [49989/26]
309. Deputy Erin McGreehan asked the Minister for Health the current status of the health technology assessment and reimbursement decision for pluvicto (lutetium-177 PSMA therapy) for the treatment of metastatic castration-resistant prostate cancer; the timeline for a final determination; and if she will make a statement on the matter. [50111/26]
310. Deputy Erin McGreehan asked the Minister for Health the steps being taken to ensure Irish patients have timely and equitable access to innovative oncology treatments, including radioligand therapies such as pluvicto; and the way Ireland compares with other EU Member States in access to such treatments. [50112/26]
311. Deputy Erin McGreehan asked the Minister for Health the current capacity within the public health system to deliver radioligand therapies, including the availability of nuclear medicine facilities, trained personnel, and radiopharmacy supports; and the plans in place to expand this capacity. [50113/26]
312. Deputy Erin McGreehan asked the Minister for Health whether her Department has undertaken or commissioned any strategic review of Ireland's nuclear medicine and radiopharmacy infrastructure; and the actions planned to develop a sustainable, indigenous capability in this area. [50114/26]
313. Deputy Erin McGreehan asked the Minister for Health if consideration is being given to developing a national strategy for radiopharmaceutical production and usage, in light of increasing global demand and supply constraints; and if she will outline any engagement with industry, academia, or international partners on this issue. [50115/26]
314. Deputy Erin McGreehan asked the Minister for Health the level of capital and operational investment allocated to nuclear medicine and advanced cancer therapies over the past five years; and the projected investment over the next five years to support emerging treatments such as radioligand therapies. [50116/26]
315. Deputy Erin McGreehan asked the Minister for Health the current number of specialists in nuclear medicine, radiopharmacy, and medical physics in Ireland; the projected workforce requirements to support expansion in radioligand therapies; and the plans to address any identified gaps. [50117/26]
316. Deputy Erin McGreehan asked the Minister for Health the supports in place to enable Irish participation in international clinical trials involving radiopharmaceuticals and targeted radionuclide therapies; and the way in which Ireland can position itself as a hub for such research. [50118/26]
317. Deputy Erin McGreehan asked the Minister for Health the extent of engagement with patient advocacy organisations, including those representing prostate cancer patients, in relation to the reimbursement and provision of new treatments such as pluvicto. [50119/26]
318. Deputy Erin McGreehan asked the Minister for Health if she will support a dedicated session of the relevant Oireachtas Committee to examine the case for investment in nuclear medicine and radiopharmacy infrastructure, including emerging cancer therapies; and if officials from her Department would be available to attend. [50120/26]
319. Deputy Erin McGreehan asked the Minister for Health if she will provide an update on the review of the operation of Drogheda Cottage Hospital; when this review is expected to be completed; and if she can give assurances that the hospital will remain open. [50125/26]
311. Deputy Erin McGreehan asked the Minister for Enterprise, Tourism and Employment the measures being considered to address the impact of rising labour, energy and utility costs on rural pubs; and if he will make a statement on the matter. [49624/26]
499. Deputy Erin McGreehan asked the Minister for Housing, Local Government and Heritage the number of domestic wastewater treatment system inspections carried out in each local authority area in each of the years 2023, 2024, and to-date in 2026; and the failure rate identified in each year. [49452/26]
500. Deputy Erin McGreehan asked the Minister for Housing, Local Government and Heritage the number of private wells identified as contaminated due to malfunctioning domestic wastewater treatment systems in the past five years. [49455/26]
501. Deputy Erin McGreehan asked the Minister for Housing, Local Government and Heritage the measures in place to protect households relying on private wells from contamination caused by nearby septic tanks. [49456/26]